Use of recombinant factor VIIA plus continuous infusion of recombinant factor VIII in the hemostasis of type 3 von Willebrand disease with anaphylactic anti-VWF inhibitor

被引：0
|
作者：
Suzuki, N. [1 ]
Sanda, N. [2 ]
Matsushita, T. [3 ]
Kojima, T. [4 ]
Yamamoto, K. [3 ]
Katsumi, A. [5 ]
Hirashima, K. [1 ]
Kajiura, Y. [2 ]
Takatsu, M. [2 ]
Naoe, T. [1 ]
机构：
[1] Nagoya Univ Hosp, Nagoya, Aichi, Japan
[2] Nagoya Univ Hosp, Dept Clin Lab, Nagoya, Aichi, Japan
[3] Nagoya Univ Hosp, Dept Transfus Med, Nagoya, Aichi, Japan
[4] Nagoya Univ, Sch Hlth Sci, Dept Med Technol, Nagoya, Aichi 4648601, Japan
[5] Natl Ctr Geriatr & Gerontol, Dept Haematol, Tokyo, Japan
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-WE-459
引用
收藏
页码：665 / 665
页数：1
相关论文
共 50 条
  • [31] Heart transplant in a factor VIII-deficient patient with a high-titre inhibitor: perioperative management using high-dose continuous infusion factor VIII and recombinant factor VIIa
    Sheth, S
    DiMichele, D
    Lee, M
    Lamour, J
    Quaegebeur, J
    Hsu, D
    Addonizio, L
    Piomelli, S
    HAEMOPHILIA, 2001, 7 (02) : 227 - 232
  • [32] Continuous infusion of von Willebrand factor and factor VIII (Haemate(R) HS) after elective heart surgery in a child with von Willebrand disease type III.
    Kuhne, T
    Caliezi, C
    Imbach, P
    Marbet, GA
    BLOOD, 1997, 90 (10) : 3311 - 3311
  • [33] Continuous infusion of recombinant porcine factor VIII for neurosurgical management of intracranial haemorrhage in a patient with severe haemophilia A with factor VIII inhibitor
    Ruan, Gordon J.
    Mao, Jimmy J.
    Sytsma, Terin T.
    Akogyeram, Ivy I.
    Wang, Yucai
    Ashrani, Aneel A.
    Pruthi, Rajiv K.
    HAEMOPHILIA, 2020, 26 (03) : E141 - E144
  • [34] Recombinant von Willebrand factor -: Insight into structure and function through infusion studies in animals with severe von Willebrand disease
    Schwarz, HP
    Schlokat, U
    Mitterer, A
    Váradi, K
    Gritsch, H
    Muchitsch, EM
    Auer, W
    Pichler, L
    Dorner, F
    Turecek, PL
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2002, 28 (02): : 215 - 225
  • [35] The use of recombinant activated factor VII in congenital and acquired von Willebrand disease
    Franchini, Massimo
    Veneri, Dino
    Lippi, Giuseppe
    BLOOD COAGULATION & FIBRINOLYSIS, 2006, 17 (08) : 615 - 619
  • [36] Partial success of recombinant activated factor VIIa (rFVIIa) in severe hemorrhage in acquired von Willebrand disease
    Atallagh, F.
    Georges, B.
    Riu, B.
    Conil, J. M.
    Decun, J. F.
    Caranobe, C.
    Rischmann, P.
    Samii, K.
    Boneu, B.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2004, 21 : 81 - 81
  • [37] In vitro and in vivo stability of diluted recombinant factor VIII for continuous infusion use in haemophilia A
    Revel-Vilk, S.
    Blanchette, V. S.
    Schmugge, M.
    Clark, D. S.
    Lillicrap, D.
    Rand, M. L.
    HAEMOPHILIA, 2010, 16 (01) : 72 - 79
  • [38] Treatment of acute haemorrhage in a patient with type 3 von Willebrand's disease and alloantibodies against von Willebrand factor with recombinant activated factor VII
    Dietrich A.
    Scholz U.
    Schreiter D.
    European Surgery, 2005, 37 (6) : 336 - 339
  • [39] Controlling acute bleeding episodes with recombinant factor VIIa in Haemophiliacs with inhibitor: continuous infusion and bolus injection
    Chuansumrit, A
    Isarangkura, P
    Angchaisuksiri, P
    Sriudomporn, N
    Tanpowpong, K
    Hathirat, P
    Jorgensen, LN
    HAEMOPHILIA, 2000, 6 (02) : 61 - 65
  • [40] Sequential treatment with bolus and continuous infusion of recombinant factor VIIa for hip arthroplasty in a patient with haemophilia A and inhibitor
    Perez, R
    Martinez, ML
    Piñero, A
    Sosa, R
    HAEMOPHILIA, 2002, 8 (06) : 822 - 825
12345